MA52012A - Modulateurs de sting (stimulateur des gènes de l'interféron) à base de cyclopentane - Google Patents
Modulateurs de sting (stimulateur des gènes de l'interféron) à base de cyclopentaneInfo
- Publication number
- MA52012A MA52012A MA052012A MA52012A MA52012A MA 52012 A MA52012 A MA 52012A MA 052012 A MA052012 A MA 052012A MA 52012 A MA52012 A MA 52012A MA 52012 A MA52012 A MA 52012A
- Authority
- MA
- Morocco
- Prior art keywords
- cyclopentane
- interferon gene
- gene stimulator
- sting modulators
- based sting
- Prior art date
Links
- 108010050904 Interferons Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862643467P | 2018-03-15 | 2018-03-15 | |
US201862666204P | 2018-05-03 | 2018-05-03 | |
US201862742532P | 2018-10-08 | 2018-10-08 | |
US201962809990P | 2019-02-25 | 2019-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52012A true MA52012A (fr) | 2021-01-20 |
Family
ID=66103038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052012A MA52012A (fr) | 2018-03-15 | 2019-03-12 | Modulateurs de sting (stimulateur des gènes de l'interféron) à base de cyclopentane |
Country Status (24)
Country | Link |
---|---|
US (4) | US10538542B2 (fr) |
EP (1) | EP3765474B1 (fr) |
JP (1) | JP7266942B2 (fr) |
KR (1) | KR20200131878A (fr) |
CN (1) | CN111918871A (fr) |
AU (1) | AU2019234043A1 (fr) |
BR (1) | BR112020018593A2 (fr) |
CA (1) | CA3093631C (fr) |
CL (1) | CL2020002352A1 (fr) |
CR (1) | CR20200382A (fr) |
DO (1) | DOP2020000160A (fr) |
EC (1) | ECSP20057847A (fr) |
ES (1) | ES2923298T3 (fr) |
IL (1) | IL277278A (fr) |
MA (1) | MA52012A (fr) |
MX (1) | MX2020009587A (fr) |
NI (1) | NI202000058A (fr) |
PE (1) | PE20210412A1 (fr) |
PH (1) | PH12020551486A1 (fr) |
RU (1) | RU2020130048A (fr) |
SG (1) | SG11202008102VA (fr) |
TW (1) | TWI741268B (fr) |
UY (1) | UY38145A (fr) |
WO (1) | WO2019175776A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111566120B (zh) | 2017-12-20 | 2023-09-29 | 捷克共和国有机化学与生物化学研究所 | 活化sting转接蛋白的具有膦酸酯键的3’3’环状二核苷酸 |
JP7098748B2 (ja) | 2017-12-20 | 2022-07-11 | インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. | Stingアダプタータンパク質を活性化するホスホン酸結合を有する2’3’環状ジヌクレオチド |
US10538542B2 (en) * | 2018-03-15 | 2020-01-21 | Pfizer Inc. | Cyclopentane-based modulators of STING (stimulator of interferon genes) |
TWI833744B (zh) | 2018-04-06 | 2024-03-01 | 捷克科學院有機化學與生物化學研究所 | 3'3'-環二核苷酸 |
TW202028179A (zh) | 2018-10-08 | 2020-08-01 | 美商普萊恩醫療公司 | 胺基酸化合物及使用方法 |
GEP20237572B (en) * | 2019-09-25 | 2023-11-27 | Pfizer | Polyheterocyclic modulators of sting (stimulator of interferon genes) |
TW202200136A (zh) | 2020-04-10 | 2022-01-01 | 日商小野藥品工業股份有限公司 | 癌治療方法 |
US11964978B2 (en) * | 2021-03-18 | 2024-04-23 | Pfizer Inc. | Modulators of STING (stimulator of interferon genes) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
KR20170015353A (ko) * | 2014-06-04 | 2017-02-08 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Sting의 조절제로서 사이클릭 디뉴클레오타이드 |
GB201501462D0 (en) * | 2015-01-29 | 2015-03-18 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
US10538542B2 (en) * | 2018-03-15 | 2020-01-21 | Pfizer Inc. | Cyclopentane-based modulators of STING (stimulator of interferon genes) |
-
2019
- 2019-03-11 US US16/297,910 patent/US10538542B2/en active Active
- 2019-03-11 TW TW108108048A patent/TWI741268B/zh not_active IP Right Cessation
- 2019-03-12 JP JP2020548916A patent/JP7266942B2/ja active Active
- 2019-03-12 KR KR1020207029472A patent/KR20200131878A/ko not_active Application Discontinuation
- 2019-03-12 PE PE2020001412A patent/PE20210412A1/es unknown
- 2019-03-12 CA CA3093631A patent/CA3093631C/fr active Active
- 2019-03-12 CN CN201980019494.9A patent/CN111918871A/zh active Pending
- 2019-03-12 WO PCT/IB2019/052009 patent/WO2019175776A1/fr active Application Filing
- 2019-03-12 MX MX2020009587A patent/MX2020009587A/es unknown
- 2019-03-12 BR BR112020018593-0A patent/BR112020018593A2/pt not_active IP Right Cessation
- 2019-03-12 CR CR20200382A patent/CR20200382A/es unknown
- 2019-03-12 EP EP19717149.9A patent/EP3765474B1/fr active Active
- 2019-03-12 ES ES19717149T patent/ES2923298T3/es active Active
- 2019-03-12 SG SG11202008102VA patent/SG11202008102VA/en unknown
- 2019-03-12 AU AU2019234043A patent/AU2019234043A1/en not_active Abandoned
- 2019-03-12 MA MA052012A patent/MA52012A/fr unknown
- 2019-03-12 RU RU2020130048A patent/RU2020130048A/ru unknown
- 2019-03-13 UY UY38145A patent/UY38145A/es not_active Application Discontinuation
- 2019-12-04 US US16/702,738 patent/US10968242B2/en active Active
-
2020
- 2020-08-25 DO DO2020000160A patent/DOP2020000160A/es unknown
- 2020-08-28 NI NI202000058A patent/NI202000058A/es unknown
- 2020-09-10 IL IL277278A patent/IL277278A/en unknown
- 2020-09-11 CL CL2020002352A patent/CL2020002352A1/es unknown
- 2020-09-12 PH PH12020551486A patent/PH12020551486A1/en unknown
- 2020-09-15 EC ECSENADI202057847A patent/ECSP20057847A/es unknown
-
2021
- 2021-03-03 US US17/190,924 patent/US20210230196A1/en not_active Abandoned
-
2023
- 2023-07-24 US US18/225,589 patent/US20230382932A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52012A (fr) | Modulateurs de sting (stimulateur des gènes de l'interféron) à base de cyclopentane | |
MA52709A (fr) | Administration d'adn | |
MA54676A (fr) | Vaccins à base d'arn contre le vrs | |
MA46245A (fr) | Dinucléotides cycliques comme agonistes (stimulateur des gènes de l'interféron) | |
DK3399984T3 (da) | Modulatorer af 5'-nukleotidase, ecto og anvendelsen deraf | |
IL276844A (en) | Interferon gene stimulator agonists and their uses | |
CL2020000173S1 (es) | Masajeador. | |
UA42295S (uk) | Комп'ютер | |
MA46923A (fr) | Compositions à base d'arni ciblant le gène serpina1 et leurs méthodes d'utilisation | |
DK3911354T3 (da) | AVV-formidlet genterapi, der genskaber otoferlin-genet | |
MA54386A (fr) | Modulateurs de trex1 | |
MA53721A (fr) | Modulateurs de la monoacylglycérol lipase | |
CA185676S (fr) | Sac à dos | |
IL277921A (en) | RNA new small operators | |
DK3737399T3 (da) | Atf5-peptidvarianter og anvendelser deraf | |
MA49393A (fr) | Poly(phosphoesters) destinés à l'administration d'acides nucléiques | |
MA53722A (fr) | Modulateurs de la monoacylglycérol lipase | |
MA53924A (fr) | Modulateurs de l'expression d'apol1 | |
EP3794410A4 (fr) | Affichage électrophorétique piézoélectrique | |
MA55010A (fr) | Système d'électrodes | |
MA54825A (fr) | Modulateurs de gpr35 | |
DK3833786T3 (da) | Rekombinant nucleinsyrekonstrukt | |
MA51645A (fr) | Modulateurs de l'expression de dnm2 | |
WO2016123329A3 (fr) | Marqueurs d'expression génique et traitement de la sclérose en plaques | |
DE112020002320A5 (de) | Schmerzmedikament |